By Taylor Mixides (Drug Target Review)2023-05-25T10:00:10
A recent study led by the Lieber Institute for Brain Development has revealed that over 100 genes associated with the risk of schizophrenia appear to contribute to the development of the illness primarily through their influence on the placenta.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2023-03-30T09:15:30
Sponsored by Halo Labs
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2023-02-16T14:53:10
Sponsored by Cell Signaling Technology
2023-07-04T09:00:08
Sponsored by SB Drug Discovery
Site powered by Webvision Cloud